MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

I'm not sure how much impact this conference will have - they...

  1. 24 Posts.
    I'm not sure how much impact this conference will have - they are presenting animal models ie. preclinical data.

    Currently, the upcoming ACV1 announcement relates to Phase II trials, which is years ahead of animal models..

    That said, even if they present it at the same time during a trading halt, it will definitely aid the SP.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.